AXL | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Conferences Trial results

27 January 2025

ASCO-GI – Exelixis opens up its Cabinet again

Conferences Trial results

23 January 2025

ASCO-GI – Exelixis’s son of Cabometyx disappoints

The company might need something better to replace its ageing blockbuster.

Regulatory

27 November 2024

Cabometyx’s Cabinet committee

Deals

15 October 2024

Merck keeps its kinase inhibitor options open

Trial results

1 August 2023

Pfizer culls three phase 1 projects

Subscribe to AXL